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Abstract: This study determined the effects of increasing loads of intraduodenal (ID) dairy protein
on plasma amino acid (AA) concentrations, and their relationships with serum insulin, plasma
glucagon-like peptide-1 (GLP-1) and energy intake. Sixteen healthy men had concentrations of
AAs, GLP-1 and insulin measured in response to 60-min ID infusions of hydrolysed whey protein
administered, in double-blinded and randomised order, at 2.1 (P2.1), 6.3 (P6.3) or 12.5 (P12.5) kJ/min
(encompassing the range of nutrient emptying from the stomach), or saline control (C). Energy intake
was quantified immediately afterwards. Compared with C, the concentrations of 19/20 AAs, the
exception being cysteine, were increased, and this was dependent on the protein load. The relationship
between AA concentrations in the infusions and the area under the curve from 0 to 60 min
(AUC0´60 min) of each AA profile was strong for essential AAs (R2 range, 0.61–0.67), but more
variable for non-essential (0.02–0.54) and conditional (0.006–0.64) AAs. The AUC0´60 min for each
AA was correlated directly with the AUC0´60 min of insulin (R2 range 0.3–0.6), GLP-1 (0.2–0.6) and
energy intake (0.09–0.3) (p < 0.05, for all), with the strongest correlations being for branched-chain
AAs, lysine, methionine and tyrosine. These findings indicate that ID whey protein infused at loads
encompassing the normal range of gastric emptying increases plasma concentrations of 19/20 AAs
in a load-dependent manner, and provide novel information on the close relationships between the
essential AAs, leucine, valine, isoleucine, lysine, methionine, and the conditionally-essential AA,
tyrosine, with energy intake, insulin and GLP-1.
Keywords: dairy; whey protein hydrolysate; insulinotropic response; glycemic control; appetite
regulation; human
1. Introduction
Calorie-controlled diets with moderately increased protein content are effective in the
management of obesity due to their capacity to (i) suppress appetite [1] and, under ad-libitum feeding
conditions, reduce energy intake [2]; (ii) promote loss of fat while preserving muscle mass [3,4];
(iii) increase insulin release and reduce postprandial glycemic excursions [1,3]; and (iv) improve lipid
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metabolism and blood pressure [1,3]. These benefits, however, are often not sustained for more than
12 months, and hence, greater understanding of the mechanisms underlying these benefits is required.
Oral and intraduodenal (ID) administration of dietary protein, including whey protein isolate (in
both un-hydrolysed and hydrolysed form), like lipid and carbohydrate, modulates gastrointestinal
(GI) motor activity and hormone release in a nutrient load-dependent manner [5–7]. In turn,
these GI factors influence gastric emptying [8], postprandial glycaemia [9] and energy intake [5–7].
While whey protein isolate, co-ingested with carbohydrate, improves glycaemia by slowing gastric
emptying and stimulating the release of glucagon-like peptide-1 (GLP-1) and/or glucose-dependent
insulinotropic polypeptide (GIP) as well as insulin [10], our recent observations indicate that the effects
of lipid–protein combinations on these gut hormones are related directly to the amount of lipid, and
the effects on insulin and glucagon are related to the amount of protein, whereas the effects on energy
intake appear dependent on a threshold load of ~12.5 kJ/min (or 3 kcal/min) of either nutrient being
delivered to the duodenum [11]. This study also demonstrated that the effects of ID infused hydrolysed
whey protein isolate (which did not contain fat or carbohydrate and was delivered at 12.5 kJ/min) on
the GI factors were weaker than those of isocaloric lipid [11] suggesting the suppression of energy
intake by protein may be dependent on additional mechanisms.
Several studies have reported modest associations between increased postprandial plasma
essential amino acid (AA) concentrations, particularly the branched chain AAs, leucine, isoleucine
and valine, with either an increased release of some gut hormones (particularly GLP-1 and GIP),
insulin, or reduced energy intake [12–14]. Moreover, there is some evidence that other essential AAs,
including lysine, threonine, phenylalanine, tryptophan, histidine, the conditionally-essential AAs,
glutamine, arginine and tyrosine, and the non-essential AA, glutamate, may activate peripheral and
central mechanisms involved in the regulation of energy intake and glucose homeostasis, although
information is limited [15].
The aims of this study were to determine: (1) the effects of increasing loads of hydrolysed whey
protein administered ID (thus mimicking the entry of the nutrient into the duodenum and bypassing
any orosensory influences and inter-individual variations in gastric emptying), at rates reflective
of the normal range of gastric emptying, on plasma concentrations of free AAs that were present
within the whey; and (2) the relationships between plasma AA concentrations with insulin and GLP-1
concentrations and energy intake, outcomes that we have previously reported [7]. We hypothesised
that hydrolysed whey protein infused ID at loads lower than (2.1 kJ/min (P2.1)), similar to (6.3 kJ/min
(P6.3)), and toward the upper end (12.5 kJ/min (P12.5)), of normal gastric emptying rates would
modulate the release of free AAs into the blood in a load-related manner, and leucine, isoleucine, valine,
and potentially other AAs, would be related to the insulin and GLP-1 responses and energy intake.
2. Subjects and Methods
2.1. Subjects
Sixteen healthy lean men (mean age 27 ˘ 3 years, range 19–54 years; BMI 22.1 ˘ 0.6 kg/m2;
range 18.5–24.8 kg/m2) participated in the study, as described [7]. In addition to the original power
calculation [7], we calculated that n = 16 would allow us to detect relationships of r ě 0.5 between
increasing loads of protein with total plasma AAs, and increasing plasma total AA concentrations with
energy intake, plasma insulin and GLP-1 [5,6]. The Royal Adelaide Hospital Research Ethics Committee
approved the study protocol, and the study was registered as a clinical trial with the Australia and New
Zealand Clinical Trial Registry (www.anzctr.org.au, registration number 12610000376044). All subjects
provided written, informed consent, prior to their inclusion.
2.2. Study Outline
While the aim of the original study was to evaluate the effects of increasing loads of ID infusion
of hydrolysed whey protein at loads of (i) 2.1 kJ/min “P2.1”; (ii) 6.3 kJ/min “P6.3”; or (iii) 12.5 kJ/min
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“P12.5”; or (iv) a saline control “C”, at a rate of 4 mL/min for 60 min, on antropyloroduodenal motility
(APD), and gut hormone, insulin, glucose, appetite and energy intake responses [7], we have now
evaluated the effects on plasma free AAs to determine their relationships with GLP-1, insulin, and
energy intake [7].
2.3. Intraduodenal Infusions
The infusion solutions were prepared as described [7]. In brief, hydrolysed whey protein (Whey
Protein Hydrolysate 821, Fonterra Co-Operative Group Ltd, Auckland, New Zealand) was dissolved in
varying amounts of saline and water to achieve the desired loads (i.e., 2.1, 6.3 and 12.5 kJ/min, which
equated to 8, 24 and 48 g of protein over 60 min) and to ensure they were all a total volume of 240 mL
and equi-osmolar (~640–676 mOsmol/L). As a component of dairy products, whey protein is common
in the diet and has been shown to be the most satiating protein source when consumed orally [16,17].
We have used whey protein in our previous studies evaluating the role of macronutrients on GI
function and appetite [7,10,11]. Hydrolysed whey was selected because it contains di- and tri-peptide
fractions as well as larger peptides and some amino acids, and hence, more closely resembles partially
digested protein, that would be entering the small intestine following oral protein ingestion [18,19].
Infusions were prepared on the morning of each study by an investigator who was not involved in the
data analysis. The infusion apparatus was covered at all times so that both the primary investigator
and the subject were blinded to the treatment. Table 1 depicts the specific AA composition of the
hydrolysed whey protein.





Glutamic acid 1.3 (36.3) 3.8 (108.9) 7.7 (217.8)
Leucine 0.9 (29.7) 2.8 (89.1) 5.6 (178.2)
Aspartic acid 0.8 (26.5) 2.5 (79.3) 5.1 (158.7)
Lysine 0.8 (23.4) 2.5 (70.3) 5.0 (140.5)
Alanine 0.4 (20.8) 1.3 (62.4) 2.7 (124.8)
Valine 0.4 (14.7) 1.2 (44.2) 2.5 (88.4)
Proline 0.4 (14.5) 1.2 (43.4) 2.4 (86.9)
Isoleucine 0.4 (14.1) 1.3 (42.4) 2.7 (84.8)
Threonine 0.4 (13.2) 1.1 (39.5) 2.3 (79.1)
Serine 0.3 (9.9) 0.8 (29.6) 1.5 (59.2)
Phenylalanine 0.3 (7.8) 0.9 (23.4) 1.9 (46.7)
Tyrosine 0.3 (7.3) 0.9 (21.9) 1.9 (43.7)
Arginine 0.3 (5.9) 0.8 (17.8) 1.5 (35.7)
Glycine 0.2 (10.5) 0.6 (31.4) 1.1 (62.8)
Cysteine 0.2 (6.5) 0.6 (19.5) 1.1 (38.9)
Methionine 0.2 (4.9) 0.5 (14.5) 1.0 (29.1)
Histidine 0.2 (4.7) 0.5 (14.0) 1.0 (28.0)
Tryptophan 0.2 (3.9) 0.6 (11.6) 1.1 (23.1)
Glutamine Not reported
Asparagine Not reported
Total 8.0 (254) 24.0 (763) 48.0 (1526)
a The amino acid (AA) composition of “Hydrolysed Whey Protein 821” was provided by Fonterra Co-Operative
Group Ltd, Auckland, New Zealand, and glutamine and asparagine were not reported in protein product
specification; b The infusions (total volume 240 mL) consisted of 2.1 kJ/min (P2.1), 6.5 kJ/min (P6.3), or
12.5 kJ/min (P12.5) of whey protein, each infused at 4 mL/min for 60 min; c The AAs are presented in order of
most to least abundant g present within the protein infusions and glutamic acid and aspartic acid include the
contribution from asparagines and glutamine in this product specification.
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Subjects were studied on four occasions, each separated by 3–10 days, in a randomized,
double-blind, cross-over design. Randomisation was performed by an investigator not involved
in the assessments using the free software “Research Randomiser”, and the investigator performing
the assessments was blinded to the randomisation and preload conditions. Subjects were provided
with a standardised evening meal to consume the night prior to each study day, and were instructed
to abstain from all food and drinks and to refrain from strenuous physical activity, until attending
the laboratory at the Discipline of Medicine at 8:30 a.m. Upon arrival, a small-diameter (OD: 3.5 mm)
manometric catheter (total length: 100 cm, Dentsleeve International, Mui Scientific, Mississauga, ON,
Canada) was inserted into the stomach through an anesthetised nostril and allowed to pass into
the duodenum by peristalsis. The catheter contained 16 side-holes spaced at 1.5 cm intervals, with
an additional channel used for ID infusions located 11.75 cm distal to the end of the sleeve sensor
(14.5 cm from the pylorus), and was positioned as described previously [7]. Once the catheter was
positioned correctly (which took between 15 and 45 min), fasting motility was monitored until the
occurrence of a phase III of the interdigestive migrating motor complex. Immediately after cessation
of phase III activity, an intravenous cannula was placed in a right forearm vein for blood sampling.
At t = ´15 min (during motor quiescence, i.e., phase I of the migrating motor complex), a baseline
blood sample (14 mL) was taken and a visual analogue scale questionnaire (VAS) to assess appetite
perceptions and GI symptoms completed by the subject. Baseline measurement of APD motility also
commenced. At t = 0 min, the 60-min ID infusion of one of the treatments commenced. During the
infusion, APD motility was monitored continuously, and VAS ratings and blood samples were obtained
at 15-min intervals. At t = 60 min, the infusion was terminated and the ID catheter removed. Subjects
were then presented with a standardised cold, buffet-style meal, in excess of what they would be
expected to consume, and instructed to eat freely for up to 30 min (t = 60–90 min) until comfortably
full [20]. The composition of the buffet meal has been described [20].
2.4. Measurements
Plasma free AA and GLP-1 and serum insulin concentrations: 10-mL venous blood samples were
collected in ice-chilled EDTA-treated tubes for plasma AA and GLP-1 analysis, and 4-mL samples
in serum-Z tubes containing clotting beads (Sarstedt Australia Pty Ltd, Adelaide, Australia) for
insulin. Plasma/serum was separated by centrifugation at 3200 rpm for 15 min at 4 ˝C, and stored
at ´70 ˝C for later analysis. Plasma free AAs concentrations (mmol/L) of asparagine, aspartic acid,
alanine, arginine, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine,
methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine, were analysed
using precolumn derivatization with 6-aminoquinolyl-N hydroxysuccmimidyl carbamate (AQC).
The derivatives were then separated and quantified by reversed-phase high-performance liquid
chromatography (HPLC). The AAs (with the exception of tryptophan) were detected by fluorescence,
whereas tryptophan required UV detection. Before derivatisation, 100 µL of plasma samples were
diluted 1:1 with internal standard solution (Norvaline) and deproteinised by ultra-filtration through
a membrane with 10 kDa nominal molecular weight cut-off (Ultrafree MC with PL-10 membrane,
Millipore, MA, USA). AAs contained in the filtrate (100 µL) were labelled using the Waters AccQTag™
chemistry and analysed using a Waters Acquity™ UPLC system (Waters Corporation, MA, USA) [21].
Only single analysis of each AA was conducted. The analysis was performed at the Australian
Proteome Analysis’s Facility established under the Australian Government’s National Collaborative
Research Infrastructure Strategy (NCRIS). All analyses were performed by the same technician. Plasma
GLP-1 (pmol/L) and serum insulin (mU/L) were measured, as described [7].
Energy intake: The amount eaten (g) was quantified by weighing the buffet meal before and after
consumption, and energy (kJ) was then calculated using commercially available software (Foodworks,
Xyris Software, version 3.01, Highgate Hill, Australia).
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2.5. Data and Statistical Analyses
Statistical analyses were performed using SPSS software (version 19.0; SPSS Inc, IBM, New York,
NY, USA). Baseline plasma AA concentrations were analysed using one-way ANOVA with protein
load as the within-subject factor. The effect of protein load on the net incremental area under the curve
(AUC0´60min) for each AA (calculated using the trapezoidal rule) was analysed by one-way ANOVA
with protein load as the fixed factor. Post-hoc comparisons, adjusted for multiple comparisons using
Bonferroni’s correction, were performed when ANOVAs revealed significant effects. The effects of
increasing loads of protein on insulin and GLP-1 concentrations and on energy intake at a subsequent
meal have been reported [7], and additional analyses of the AUC for insulin and GLP-1 were done to
determine relationships between these outcomes with the AUC for each of the 20 AAs. Relationships
between the AUC for each AA and either protein load, total AA concentration within the infusion,
energy intake or AUC for insulin and GLP-1, respectively, were evaluated using linear within-subject
correlations (r) with AUC for each AA profile as the dependent, subject as a fixed factor and the other
variable as a covariate. Relationships between each AA with energy intake and AUCs for insulin and
GLP-1, respectively, were ranked in order of strongest to weakest, using R square values. Statistical
significance was accepted at p < 0.05; all data are presented as mean ˘ SEM.
3. Results
3.1. Plasma AA Concentrations
Baseline concentrations of individual and total AAs did not differ between test days (Table 2).
Table 2. Plasma amino acid (AA) concentrations at baseline prior to commencing each infusion a,b,c.
AA C
Treatment p Value c
P2.1 P6.3 P12.5
µmol/L
Glutamine 520 530 540 540 >0.05
Alanine 240 240 240 270 >0.05
Valine 190 190 200 190 >0.05
Glycine 180 180 190 190 >0.05
Proline 150 150 150 160 >0.05
Lysine 150 150 150 150 >0.05
Threonine 200 100 100 100 >0.05
Leucine 100 100 100 100 >0.05
Serine 90 90 90 90 >0.05
Glutamic acid 80 90 90 90 >0.05
Arginine 80 80 80 80 >0.05
Histidine 60 70 70 70 >0.05
Isoleucine 50 50 50 50 >0.05
Tyrosine 50 50 50 50 >0.05
Asparagine 40 50 50 50 >0.05
Phenylalanine 40 40 40 40 >0.05
Methionine 020 20 20 20 >0.05
Aspartic acid 3 3 3 3 >0.05
Tryptophan 3 3 3 3 >0.05
Cysteine 2 2 2 2 >0.05
Total 2130 2200 2200 2230 >0.05
a Data are means, and the amino acids (AAs) have been presented in order of most to least concentrated, n = 16;
b The infusions consisted of either saline (C), or of 2.1 kJ/min (P2.1), 6.5 kJ/min (P6.3), or 12.5 kJ/min (P12.5) of
hydrolysed whey protein, each infused at 4 mL/min for 60 min; c Main effect of protein load was determined
by one-way ANOVA and post-hoc comparisons between two loads of protein were done using Bonferroni’s
correction; statistical significance was accepted at p < 0.05.
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In response to increasing loads of ID whey protein, the greatest increases in plasma concentrations
over the 60-min infusion were observed for aspartic acid, isoleucine, leucine, lysine and methionine
(Figure 1), whereas the smallest increases were observed for glycine, glutamine, histidine, glutamic
acid and cysteine (Figure 2). The AUC0´60min of each of the 20 AA profiles in response to increasing
protein loads are depicted in Table 3. There was a significant main effect of protein load on plasma
concentrations of 19/20 AAs (p < 0.001), with the exception of cysteine. Post hoc-analyses revealed that
the AUC0´60min of plasma concentrations of 16/20 AAs (p < 0.05 for all), except tryptophan, alanine,
glycine and cysteine, were greater during P2.1 compared with C. While the AUC0´60min of the plasma
concentrations of each of the 20 AAs did not differ between P2.1 and P6.3, the AUC0´60min of all
AA profiles, apart from glutamic acid, glycine and cysteine, were greater during P12.5 than during
P2.1 (p < 0.05 for all). In addition, the AUC0´60min of 11/20 AAs, the exceptions being aspartic acid,
threonine, asparagine, alanine, serine, glutamic acid, glutamine, glycine and cysteine, were greater
during P12.5 than during P6.3 (p < 0.05 for all).
Table 3. Plasma amino acid (AA) responses (AUC0´60min) ordered from the strongest to weakest
response following the infusions, relative to control a,b,c.
AA C
Treatment p Value c
P2.1 P6.3 P12.5
µmol.60 min/L
Aspartic acid 200 300 d,e 500 d 7000 d <0.001
Isoleucine 3200 6200 d,e 8600 d,e 12,100 d <0.001
Leucine 6100 11,700 d,e 15,900 d,e 21,900 d <0.001
Lysine 9000 14,000 d,e 18,000 d,e 22,800 d <0.001
Methionine 1100 1700 d,e 2100 d,e 2900 d <0.001
Tryptophan 2000 300 e 300 d,e 4000 d <0.001
Tyrosine 2800 3800 d,e 4500 d,e 5800 d <0.001
Valine 11,300 14,600 d,e 17,500 d,e 20,800 d <0.001
Phenylalanine 2500 3200 d,e 3600 d,e 4500 d <0.001
Threonine 5800 7600 d,e 9100 d 10,500 d <0.001
Asparagine 2700 3500 d,e 4200 d 4800 d <0.001
Proline 8800 10,700 d,e 12,100 d,e 14,800 d <0.001
Alanine 14,500 17,000 e 19,200 d 23,100 d <0.001
Arginine 4600 6100 d,e 700 d,e 8400 d <0.001
Serine 5200 6500 d,e 7400 d 8000 d <0.001
Glutamic acid 4900 6100 d 6200 d 7100 d <0.001
Histidine 3900 4500 d,e 4800 d,e 5100 d <0.001
Glutamine 31,900 35,100 d,e 36,700 d 38,100 d <0.001
Glycine 10,800 11,600 12,300 d 12,800 d <0.001
Cysteine 100 100 200 100 >0.05
Total 129,000 165,000 d,e 190,000 d,e 225,000 d <0.001
a Data are means, and the amino acids (AAs) have been presented in order of most to least concentrated, n = 16;
b The infusions consisted of either saline (C), or of 2.1 kJ/min (P2.1), 6.5 kJ/min (P6.3), or 12.5 kJ/min (P12.5) of
hydrolysed whey protein, each infused at 4 mL/min for 60 min; c Main effect of protein load was determined
by one-way ANOVA, and post-hoc comparisons between two loads were done using Bonferroni’s correction;
statistical significance was accepted at p < 0.05; d Significantly different from C (p < 0.05); e Significantly different
from P12.5 (p < 0.05).




Figure  1. The  temporal profiles of  (a)  aspartic  acid;  (b)  isoleucine;  (c)  leucine;  (d)  lysine;  and  (e) 













Figure 1. The temporal profiles of (a) aspartic acid; (b) isoleucine; (c) leucine; (d) lysine; and
(e) methionine, the five amino acids whose plasma concentrations increased the most in response
to increasing loads of ID protein. Data are means ˘ SEM, n = 16. The infusions consisted of either
saline (C), or of 2.1 kJ/min (P2.1), 6.5 kJ/min (P6.3), or 12.5 kJ/min (P12.5) of hydrolysed whey protein,
each infused at 4 mL/min for 60 min. Main effect of protein load was determined by one-way ANOVA
and post-hoc comparisons between two loads were done using Bonferroni’s correction; statistical
significance was accepted at p < 0.05. * Significantly different from C. # Significantly different from
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Figure 2. The temporal profiles of (a) glycine; (b) glutamine; (c) histidine; (d) cysteine; and (e) glutamic
acid, the five amino acids whose plasma concentrations increased the least in response to increasing
loads f ID protein. Data are means ˘ SE , ; he infusions consisted of either saline (C), or of
2.1 kJ/ in (P2.1), 6.5 kJ/min (P6.3), or 12.5 in (P12.5) of hydrolysed hey prot in, each infused at
4 mL/ in for 60 min; Main effect of protein l s determined by one-way ANOVA and p st-hoc
comparisons between two loads were done using Bonferroni’s correction; statistical significance was
accepted at p < 0.05. * Significantly different from C. # Significantly different from P12.5 (p < 0.05).
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Strong positive relationships between protein load and the resultant AUC0´60min of the plasma
concentrations of all essential AAs were evident (i.e., range of R2 values was 0.58–0.69; p < 0.001 for all),
whereas the strength of the relationships was more variable for non-essential (i.e., 0.28–0.55; p < 0.05
for all) and conditional (i.e., 0.01–0.66; p < 0.05 for all) AAs. In addition, plasma concentrations of
essential AAs reflected closely their concentrations in the infused whey protein (i.e., range of R2 values
was 0.61–0.67; p < 0.001 for all), whereas the relationships were more variable for non-essential (i.e.,
0.02–0.54; p < 0.001 for all) and conditional (i.e., 0.006–0.64; p < 0.01 for all; the exception being cysteine
which was not related) AAs.
3.2. Serum Insulin and Plasma GLP-1 Concentrations, and Energy Intake and Amount of Food Consumed at
the Buffet Meal
For the purpose of the current analysis, the temporal profiles of insulin and GLP-1 that were
reported previously [7] have been expressed as AUCs. Table 4 depicts the AUCs0´60min of the serum
insulin, and plasma GLP-1, concentrations, and energy intake and the amount of food consumed at
the buffet meal, in response to increasing loads of protein.
Table 4. Serum insulin and plasma GLP-1 responses (AUCs0´60min), and energy intake and amount of
food consumed at the buffet meal, in response to increasing loads of ID protein a,b,c.
Hormone and Food
Intake Response C P2.1 P6.3 P12.5 p Value
c
Insulin (mU.60min/L) 150 ˘ 19 354 ˘ 94 d 721 ˘ 99 d 1087 ˘ 145 d,e <0.05
GLP-1 ( mmol.60min/L) 1489˘113 1698 ˘ 142 2053 ˘ 159 d,f 2147 ˘ 171 d,f <0.05
Energy intake (buffet; kJ) 5173 ˘ 464 4981 ˘ 473 4504 ˘ 523 g 3814 ˘ 502 d,e,f <0.05
Amount of food eaten (g) 1261 ˘ 102 1196 ˘ 104 1109 ˘ 118 1009 ˘ 107 0.08
a Data are means, and the amino acids (AAs) have been presented in order of most to least concentrated, n = 16;
b The infusions consisted of either saline (C), or of 2.1 kJ/min (P2.1), 6.3 kJ/min (P6.3), or 12.5 kJ/min (P12.5) of
hydrolysed whey protein, each infused at 4 mL/min for 60 min; c Main effect of protein load was determined
by one-way ANOVA and post-hoc comparisons between two loads were done using Bonferroni’s correction;
statistical significance was accepted at p < 0.05; d Significantly different from C (p < 0.05); e Significantly different
from P6.5 (p < 0.05); f Significantly different from P2.1 (p < 0.05); g Trend for significant difference from P2.1
(p < 0.05).
3.3. Relations between Insulin GLP-1 and Energy Intake with Plasma AA Concentrations
AUCs0´60min of plasma concentrations for 19/20 AAs (the exception being cysteine) were related
inversely to energy intake (R2 ranged between 0.09 and 0.3, p < 0.05), and directly to AUCs0´60min of
the serum/plasma concentrations of insulin (R2 ranged between 0.3 and 0.6, p < 0.01) and GLP-1 (R2
ranged between 0.2 and 0.6, p < 0.05), respectively. Figure 3 illustrates the strength of the relationships
between the AUCs of each of the 20 AA profiles with energy intake as well as the AUCs of the
insulin and GLP-1 profiles. The essential AAs, leucine, valine, isoleucine, lysine, methionine, and the
conditionally-essential AA, tyrosine, yielded the strongest correlations with all three outcomes.
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catabolised in the GI tract [22]. 
Figure 3. Relationships (ranked in order of strongest to weakest using R2 l s) betw en the AUC for
each of the 20 amino acids with the AUC for (a) energy intake; (b) insulin; and (c) glucagon-like
peptide-1 (GLP-1) following the 12.5 kJ/min (P12.5) infusion of whey protein, administered at
4 mL/min for 60 min. Data are correlation coefficients for n = 16 subjects. Statistical significance
was accepted at p < 0.05.
4. Discussion
This study has tablished that (i) increasing loads of ID whey protein hy rolysate led to
load-dep dent increas i the plasma concentrations of 19/20 free AAs ov r a 60-min period;
(ii) plasma concentrations of the essential AAs reflected closely their concentrations in the infused
whey protein, whereas the relationships were more variable for the non-essential and conditional AAs;
and (iii) changes in plasma concentrations of the essential AAs, leucine, valine, isoleucine, methionine
and lysine, and the conditionally-essential AA, tyrosine, were most closely associated with changes in
energy intake, serum insulin and plasma GLP-1.
The first aim of this study was to determine the plasma concentrations of the 20 free AAs reaching
the peripher l circulation in response to increasing loads of ID 18.1% hy rolysed whey protein.
The findings i this study indicate that wh y protein delivered to the duodenu at rat s lower than
(2.1 kJ/min), comparable to (6.3 kJ/min), and tow rds the upper end (12.5 kJ/min) of the normal
range for gastric emptying, increased, in a load-dependent manner, the plasma concentrations of
19/20 AAs. While plasma concentrations of the majority of AAs were increased by a whey protein load
as low as 2.1 kJ/min, a load of ě6.3 kJ/min was required to increase alanine, glycine and tryptophan
above control concentrations. Notably, cysteine was the only AA that was not increased by any
load, confirming previous reports from studies using pig models indicating that cysteine is readily
catabolised in the GI tract [22].
A limited number of studies have reported that concentrations of specific AAs reaching the
peripheral circulation closely resemble their concentrations in the ingested protein source [23,24].
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In contrast, other studies have found no relationships with any AA [25–27], or strong relationships only
for the branched-chained AAs [13,14,28,29]. These discrepant observations may be accounted for by the
use of high-protein drinks that included additional macronutrients, differing protein sources (i.e., dairy
vs. plant protein, and also un-hydrolysed vs. hydrolysed proteins), oral administration (affecting gastric
emptying), differences in the load of protein administered between individuals (e.g., prescription
based on a g per kg total body weight or, per kg of fat free mass), and lack of standardisation of the
meal immediately preceding the study. While our findings establish strong within-subject relationships
between plasma concentrations of all essential AAs with their concentration in the infused protein load,
there were also strong relationships with the conditional AAs, arginine, tyrosine and proline, while
relationships for the non-essential AAs, aspartic acid, alanine and glutamic acid, or the conditional AAs,
serine, glutamine, and glycine, were weak to moderate. Taken together, our observations highlight
existing, although poorly appreciated, knowledge that plasma AA concentrations are modulated
simultaneously by many factors including (i) the rates at which “free” AAs and di- and tri-peptides
are taken up by the intestinal mucosa; (ii) the digestion and absorption of endogenous small intestinal
protein; (iii) metabolic transformation during absorption (which is particularly extensive for the
dicarboxylic AAs, glutamic and aspartic acids); and (iv) rates of uptake and release of AAs by the liver
and other tissues [30].
A further aim of this study was to determine the relationships between plasma concentrations of
the 20 free AAs with the changes in serum insulin and plasma glucagon-like peptide-1 concentrations
as well as energy intake in response to ID whey protein hydrolysate, reported previously [7].
Several studies have found modest associations between increased postprandial plasma concentrations
for the essential AAs with either an increased release of some gut hormone (particularly GLP-1 and
GIP) and/or insulin, and/or with a reduced energy intake [12–14]. A major strength of the current
study was that the relationships of all 20 AAs with all three outcomes were assessed concurrently.
This analysis was performed based on emerging evidence, in both rodents and humans, that leucine,
glutamate, tryptophan, tyrosine and histidine (glutamate is a neurotransmitter and the latter three are
all precursors of neurotransmitters), as well as lysine, threonine, phenylalanine, arginine and glutamine,
can directly stimulate GLP-1 and insulin, and/or indirectly activate vagal pathways connecting the
gut with the brain [31–33]. We have demonstrated that postprandial concentrations of all AAs, apart
from cysteine, were correlated moderately with protein-induced suppression of energy intake, and
strongly with postprandial concentrations of insulin and GLP-1. In addition, after ranking each AA
based on the strength of their relationship with energy intake and AUCs of insulin and GLP-1 profiles,
respectively, we observed that the essential AAs, leucine, valine, isoleucine, methionine and lysine,
and the conditionally-essential AA, tyrosine, were the AAs that were most strongly correlated to
all of these outcomes. While we recognise that relationships do not imply causality, our findings
strongly indicate the need for further investigation of the role of these select AAs in the regulation of
glucose homeostasis and energy intake using a study design that can directly determine the effects of
isolated AAs.
Several aspects of our study design should be recognised when interpreting our results. Only
healthy, lean males were included, and hence, the findings should not be generalised to females and
obese people because they tend to be less sensitive to dietary manipulation [34], and insulin and GLP-1
concentrations and energy intake are affected by the menstrual cycle [35]. Although the total loads of
protein delivered (i.e., 8, 24 and 48 g, respectively) are representative of loads consumed in a snack
or within a main meal, the observed findings may be different for other dairy or non-dairy protein
sources, or if the protein was consumed orally or infused intragastrically. In addition, the effects of
hydrolysed whey protein isolate are not necessarily generalizable to whole dairy and non-dairy protein
foods which contain varying amounts of fat and carbohydrate and other dairy, or non-dairy, bioactives.
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5. Conclusions
In conclusion, this study provides new insights into the concentrations of 20 amino acids reaching
the peripheral circulation following defined loads of whey protein that were infused intraduodenally
to reflect the lower, middle and upper rate of the normal gastric emptying range for nutrients in
human subjects. In addition, the study has identified relationships between the concentrations of some
of these amino acids (particularly leucine, valine, isoleucine, lysine, methionine and tyrosine) with
specific GI and gluco-regulatory functions, as well as energy intake. Collectively, these findings make
an important contribution to a comprehensive understanding of the glycaemic and satiety effects of
dietary protein for the management of obesity.
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GIP glucose-dependent insulinotropic polypeptide
PYY peptide YY
AA area amino acids
AUC0´60min area under the curve from 0 to 60 min
P2.1 protein load 2.1 kJ/min
P6.3 protein load 6.3 kJ/min
P12.5 protein load 12.5 kJ/min
C saline control
APD antropyloroduodenal motility
VAS visual analog scale questionnaire
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